Envoy Medical, Inc. COCH
0.72
0.00
0.00%
as of 25 Sep
- Market cap
- $55.4M
- P/E
- 0.0×
Follow COCH
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 214.32% | 400.01% | 184.92% | 218.49% |
+8 more TTM periods Free account |
|
| (168.14%) | (139.91%) | (285.25%) | (325.53%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(278.88%) | (171.16%) | 674.72% | 1,352.77% | |
Average Days of Receivables |
116.38 | 74.87 | 80.27 | 94.76 | |
Free Cash Flow per Share |
(0.21) | (0.30) | (0.79) | (0.78) | |
Free Cash Flow |
(21.71) | (20.54) | (18.38) | (17.08) | |
Capital Expenditures |
(0.18) | — | (0.18) | 0.53 | |
Piotroski F-Score |
4.00 | 4.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(93.70%) | (57.99%) | 216.19% | 428.92% | |
Accounts Receivable Turnover |
3.21 | 4.14 | 0.55 | 1.47 | |
Accounts Payable Turnover |
0.55 | 0.57 | 0.38 | 0.37 | |
Inventory Turnover |
0.63 | 0.61 | 0.54 | 0.50 | |
Average Days of Payables |
739.08 | 645.68 | 1,219.45 | 1,193.37 | |
Days of Inventory on Hand |
573.47 | 565.92 | 645.64 | 729.55 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6,776.33% | 5,717.95% | 5,180.91% | 5,001.92% | |
Selling, General and Administrative Expense of Revenue |
4,249.28% | 3,852.56% | 3,797.10% | 4,527.40% | |
Share Based Compensation of Revenue |
467.63% | 370.94% | 309.13% | 376.44% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.76 | 0.73 | 0.64 | 0.62 | |
Depreciation/Fixed assets |
1.34 | 1.31 | 1.22 | 1.12 | |
Capex/Depreciation |
(0.14) | 0.00 | (0.14) | 0.42 | |
Revenue per Share |
0.00 | 0.00 | 0.01 | 0.01 | |
Operating CF per Share |
(0.21) | (0.30) | (0.78) | (0.81) | |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.02 | |
Capex to Sales |
0.86 | 0.00 | 0.74 | (2.53) | |
Net Profit Margin |
(13,747.34%) | (12,020.09%) | (11,892.95%) | (13,755.29%) |
Columns are period end dates